blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP4366720

EP4366720 - THE USE OF BETA-HYDROXYBUTYRATES FOR THE TREATMENT OR PREVENTION OF ANEURYSMS AND DISSECTIONS [Right-click to bookmark this link]
StatusRequest for examination was made
Status updated on  12.04.2024
Database last updated on 13.09.2024
FormerThe international publication has been made
Status updated on  13.01.2023
Most recent event   Tooltip13.09.2024Change: Validation statespublished on 16.10.2024 [2024/42]
13.09.2024Change - extension statespublished on 16.10.2024 [2024/42]
Applicant(s)For all designated states
Georgia State University Research Foundation, Inc.
30 Courtland Street
Atlanta, GA 30303 / US
[2024/20]
Inventor(s)01 / ZOU, Ming-Hui
Peachtree Corners, Georgia 30097 / US
02 / HAN, Young-Min
Buford, Georgia 30519 / US
 [2024/20]
Representative(s)Wright, Simon Mark
Schlich Ltd
9 St. Catherine's Road
Littlehampton, West Sussex BN17 5HS / GB
[2024/20]
Application number, filing date22838614.009.07.2022
[2024/20]
WO2022US73582
Priority number, dateUS202163220086P09.07.2021         Original published format: US 202163220086 P
[2024/20]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO2023283654
Date:12.01.2023
Language:EN
[2023/02]
Type: A1 Application with search report 
No.:EP4366720
Date:15.05.2024
Language:EN
The application published by WIPO in one of the EPO official languages on 12.01.2023 takes the place of the publication of the European patent application.
[2024/20]
Search report(s)International search report - published on:US12.01.2023
ClassificationIPC:A61K31/19, A61P9/14
[2024/20]
CPC:
A61P9/14 (EP); A61K31/19 (EP); A61K31/22 (EP);
A61K45/06 (EP); C12Q1/6883 (EP); C12Q2600/156 (EP);
G01N2800/52 (EP); G01N33/5308 (EP) (-)
Designated contracting statesAL,   AT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   RS,   SE,   SI,   SK,   SM,   TR [2024/20]
TitleGerman:VERWENDUNG VON BETA-HYDROXYBUTYRATEN ZUR BEHANDLUNG ODER PRÄVENTION VON ANEURYSMEN UND DISSEKTIONEN[2024/20]
English:THE USE OF BETA-HYDROXYBUTYRATES FOR THE TREATMENT OR PREVENTION OF ANEURYSMS AND DISSECTIONS[2024/20]
French:UTILISATION DE BÊTA-HYDROXYBUTYRATES POUR LE TRAITEMENT OU LA PRÉVENTION D'ANÉVRISMES ET DE DISSECTIONS[2024/20]
Entry into regional phase01.02.2024National basic fee paid 
01.02.2024Search fee paid 
01.02.2024Designation fee(s) paid 
01.02.2024Examination fee paid 
Examination procedure01.02.2024Examination requested  [2024/20]
16.08.2024Amendment by applicant (claims and/or description)
Fees paidRenewal fee
11.06.2024Renewal fee patent year 03
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Cited inInternational search[Y]US2007173787  (HUANG MARK C T [US], et al) [Y] 20-22 * entire document *;
 [Y]US2007282247  (DESAI TEJAL [US], et al) [Y] 1-3, 15, 17-42 * entire document *;
 [A]WO2010021766  (ISIS INNOVATION [GB], et al) [A] 1-3, 15, 17-42* entire document *;
 [Y]US2010197563  (WIGHT THOMAS N [US], et al) [Y] 23, 34, 35 * entire document *;
 [Y]US2011028331  (MILEWICZ DIANNA M [US], et al) [Y] 37-39 * entire document *;
 [Y]US2012283269  (BLAGOSKLONNY MIKHAIL V [US], et al) [Y] 26 * entire document, *;
 [Y]US2016209428  (NAVIAUX ROBERT K [US], et al) [Y] 40, 41 * entire document *;
 [Y]US2016339019  (LABERGE REMI-MARTIN [US], et al) [Y] 24, 25, 28, 29 * entire document *;
 [Y]US2020289444  (THOMAS WEIMBS [US], et al) [Y] 32, 33 * entire document *;
 [Y]CN112176003  (ZHUHAI MEDPHA BIOTECHNOLOGY CO LTD) [Y] 1-3, 15, 17-42 * see machine translation *
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.